BCL2L1 Peptide - N-terminal region (AAP30258)

BCL2L1 Peptide - N-terminal region (AAP30258)
Artikelnummer
AVIAAP30258-100UG
Verpackungseinheit
100µg
Hersteller
Aviva Systems Biology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Description of Target: This is a synthetic peptide designed for use in combination with anti-BCL2L1 antibody (Catalog #: AVARP02002_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Key Reference: Xu,C., (2008) J. Biol. Chem. 283 (17), 11477-11484

Molecular Weight: 26kDa

Product Format: Lyophilized powder

Protein Size: 233
Mehr Informationen
Artikelnummer AVIAAP30258-100UG
Hersteller Aviva Systems Biology
Hersteller Artikelnummer AAP30258-100UG
Green Labware Nein
Verpackungseinheit 100µg
Mengeneinheit STK
Methode Western Blotting
Human Gene ID 598
Produktinformation (PDF)
×
MSDS (PDF)
×